unknown by Matthew Reinhard et al.
BioMed Central
Page 1 of 1
(page number not for citation purposes)
Annals of General Psychiatry
Open AccessPoster presentation
Discrepancies between self-report and objective measures among 
HIV+ stimulant users: cognitive, psychological, and behavioral 
health correlates
Matthew Reinhard*1, Charles Hinkin1, Terry Barclay1, Andrew Levine1, 
Michael Cole1, Steven Castellon1, Thomas Newton1, Douglas Longshore1, 
Ramani Durvasula2 and Sarah Marion3
Address: 1UCLA-Neuropsychiatric Institute, USA, 2Cal-State, Los Angeles, USA and 3Point Loma Nazarene University, USA
* Corresponding author    
Background
While it has long been recognized that self-reported drug
use may be at variance with objective data such as urine
toxicology assays, few studies have explored the behavio-
ral correlates of such discrepancies. The goals of the cur-
rent project were to identify a sub-group with
discrepancies between data obtained via the two methods
and characterize this sub-group in terms of their neu-
ropsychological functioning, medication adherence rates,
and approach to self-report measures.
Materials and methods
Participants were 166 ethnically diverse, community
dwelling, HIV seropositive adults (138 male, 28 female)
recruited as part of a study of antiretroviral medication
adherence. Average age was 41.3 (6.6). The UCLA Brief
Drug History Questionnaire (UCLA-BDH) was used to
ascertain self-reported stimulant drug use, and urine toxi-
cology screening was used as the objective measure of
stimulant drug use. Participants completed a battery of
commonly used, standardized neuropsychological tests
and the Millon Clinical Multiaxial Inventory- III (MCMI-
III).
Results
After matching the urinalysis results (positive or negative)
for stimulant drugs with the participants' self-report, three
groups were identified: "Discrepants" (n = 29) (negative
self report matched with positive urinalysis), "True Posi-
tives" (n = 29), and "True Negatives" (n = 104). ANOVA
revealed that the discrepant group had the poorest medi-
cation adherence, cognitive performance, and were more
defensive than the other groups.
Discussion
A sub-group of HIV-infected individuals were identified
that are likely to be at greater risk for poor health out-
comes. The present study underscores the need to verify
patient self-report, particularly with regards to sensitive
areas of inquiry such as drug use and medication adher-
ence.
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